ArticleProceedings of the National Academy of Sciences of the United States of America2016

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.

Kathrin Thell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.